Genentech, Roche deal

GNE will promote Roche's Roferon-A (interferon alfa-2a) in the U.S. for its approved

Read the full 137 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE